Masimo (MASI) Stock Forecast & Price Target

Masimo Corp's positive outlook is supported by growth in both its core SET pulse oximetry business and advanced monitoring technologies, with projected total revenue growth expected to accelerate due to impactful new product launches. The company has successfully increased its international market share for pulse oximeters and anticipates more than 10% growth from advanced monitoring platforms, contributing to an optimistic financial trajectory. Furthermore, projected EBIT margins are set to improve, with increases of approximately 70 and 60 basis points year-over-year anticipated for FY26 and FY27, reinforcing Masimo's strong profitability potential.

The negative outlook for Masimo Corp's stock is primarily driven by anticipated financial challenges, including a projected $16 million to $17 million adverse impact from tariffs, which could adversely affect operating margins by approximately 110 basis points. Additionally, the company faces significant risks that include increased competition, pricing pressure, and potential delays in product rollouts and order fulfillment, all of which may hinder revenue growth and profitability. Furthermore, the outlook remains uncertain due to the lumpy nature of quarterly revenue driven by fluctuations in installations and orders, raising concerns about the predictability of financial performance.